| Name: | Description: | Size: | Format: | |
|---|---|---|---|---|
| 389.53 KB | Adobe PDF |
Advisor(s)
Abstract(s)
We report on the clinical, biochemical, and genetic findings of a large family with the classical phenotype of Fabry disease due to the novel nonsense mutation c.607G>T (p.E203X) of the GLA gene, which occurs in the active site of the α-galactosidase A enzyme. This report highlights that (i) Fabry disease diagnosis should be considered in all cases of unexplained left ventricular hypertrophy (LVH), even in its milder forms; (ii) a complete evaluation of patients with unexplained LVH is important to find diagnostic red flags of treatable causes of LVH, such as Fabry disease; (iii) cascade family screening is paramount to the earlier diagnosis and treatment of other affected family members; and (iv) the Fabry disease phenotype is highly variable in heterozygote females, even within the same family.
Description
Keywords
Classical Phenotype Fabry Disease GLA Gene Left Ventricular Hypertrophy Mutation Nonsense Doenças Genéticas
Pedagogical Context
Citation
Cardiology. 2017;137(2):67-73. doi: 10.1159/000455117. Epub 2017 Feb 3.
Publisher
Karger Publishers
